Janitri Innovations Private Limited

Janitri Innovations Private Limited, based in Bengaluru, India, specializes in developing advanced health monitoring solutions for mothers and newborns, focusing on improving maternal and neonatal care through innovative medical technology. Founded in 2016, Janitri Innovations Private Limited focuses on maternal, fetal, and newborn health monitoring solutions. The company has raised USD 1. 4 mn through its latest funding round on June 9, 2025.

Janitri does not have any known subsidiaries or parent companies. The founder's background is not publicly available. They have completed 1 deal to date. Janitri specializes in innovative maternal, fetal, and newborn health monitoring solutions, offering a range of medical-grade products designed to enhance pregnancy monitoring for expectant mothers and healthcare providers.

Their core offerings include a portable smart cardiotocography (CTG) machine, a beltless fetal monitoring patch, and a smart handheld fetal Doppler, all of which facilitate real-time monitoring of vital signs such as fetal heart rate and maternal health indicators. These devices are designed for ease of use and portability, allowing healthcare professionals and patients to access critical health data remotely, thereby improving decision-making and timely interventions. Janitri's solutions serve a diverse client base, including hospitals, clinics, and individual expectant mothers, and are utilized in various geographical markets, including India and Kenya, where they aim to address the challenges of maternal and neonatal care in both urban and rural healthcare settings. Janitri generates revenue through direct sales of its monitoring devices and related software solutions to healthcare providers and individual consumers.

Transactions typically occur on a B2B basis, with hospitals and clinics purchasing devices such as the Keyar CTG and Daksh monitoring systems to integrate into their maternal care protocols. Janitri offers customizable solutions tailored to the specific needs of healthcare institutions, enhancing their service offerings in antenatal and labor monitoring. While specific pricing plans are not disclosed, the company’s products are designed to be accessible and affordable, thereby promoting widespread adoption in various healthcare environments. Their flagship products are underpinned by clinical research and patented technology, ensuring they meet rigorous standards of safety and efficacy.

In June 2025, Janitri Innovations Private Limited raised USD 1. 4 mn in pre-Series A funding from tal64 syndicate, with participation from individual investors. The funds will be utilized to expand sales and support networks, enhance maternal healthcare products, develop wearable monitoring patches, and create neonatal solutions. Janitri is also planning to explore new geographic markets to introduce its innovative products, aiming for expansion into additional regions by the end of 2026.